日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

HepAssis2(®) bioartificial liver system in treating acute-on-chronic liver failure patients: Findings from a phase 1 randomised, open-label clinical trial

HepAssis2® 生物人工肝系统治疗急性加重型慢性肝衰竭患者：一项 1 期随机、开放标签临床试验的结果

期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.70620
Zhong, Zibiao; Liang, Wenjin; Dai, Yong'an; Xue, Chengbiao; Zhou, Dawei; Xu, Zhigao; Li, Ling; Pan, Li; He, Chongxiang; Zhou, Xin; Zhou, Wei; Zhou, Lihua; Liu, Zhongzhong; Xia, Zhiping; Fan, Xiaoli; Peng, Guizhu; Wang, Yanfeng; Zhou, Ping; Ye, Shaojun; Ye, Qifa
肝衰竭
毒理研究
发表日期：2026
文献求助 收藏

Retraction Note: FXR activation alleviates tacrolimus-induced post-transplant diabetes mellitus by regulating renal gluconeogenesis and glucose uptake

撤稿声明：FXR激活通过调节肾脏糖异生和葡萄糖摄取来缓解他克莫司诱导的移植后糖尿病。

期刊:Journal of Translational Medicine
影响因子:
doi:10.1186/s12967-026-07893-w
Li, Ling; Zhao, Huijia; Chen, Binyao; Fan, Zhipeng; Li, Ning; Yue, Jiang; Ye, Qifa
糖尿病
代谢
发表日期：2026
文献求助 收藏

Correction: Modulatory role of radioprotective 105 in mitigating oxidative stress and ferroptosis via the HO-1/SLC7A11/GPX4 axis in sepsis-mediated renal injury

更正：放射防护剂105通过HO-1/SLC7A11/GPX4轴在脓毒症介导的肾损伤中发挥调节作用，减轻氧化应激和铁死亡。

期刊:Cell Death Discovery
影响因子:7
doi:10.1038/s41420-025-02668-6
Duo, Hong; Yang, Yanwei; Luo, Jun; Cao, Yumeng; Liu, Qian; Zhang, Jiarui; Du, Siqi; You, Jian; Zhang, Guqin; Ye, Qifa; Pan, Huaqin
氧化应激
炎症/感染
败血症
铁死亡
GPX4
肾损伤
毒理研究
发表日期：2025
文献求助 收藏

The immune duality of osteopontin and its therapeutic implications for kidney transplantation

骨桥蛋白的免疫双重性及其在肾移植中的治疗意义

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1520777
Leung, Junto; Qu, Lei; Ye, Qifa; Zhong, Zibiao
免疫/内分泌
发表日期：2025
文献求助 收藏

RP105 exerts hepatoprotective effects in sepsis by modulating the SOCS2/JAK2/STAT3 signaling pathway.

RP105 通过调节 SOCS2/JAK2/STAT3 信号通路在脓毒症中发挥肝脏保护作用。

期刊:International Journal of Molecular Medicine
影响因子:5.8
doi:10.3892/ijmm.2025.5666
Deng Qin, Duo Hong, Ye Qifa, Chen Ruoping, Fu Zhihui, Xiao Jiansheng, Pan Huaqin, Xiao Qi
炎症/感染
信号转导
JAK/STAT
败血症
JAK2
STAT3
发表日期：2025
文献求助 收藏

CXCR6 recruits Th2 cells and promotes liver fibrosis in schistosomiasis japonica

CXCR6 募集 Th2 细胞并促进日本血吸虫病肝纤维化

期刊:Hepatology Communications
影响因子:4.6
doi:10.1097/HC9.0000000000000784
Zhang, Yu; Luo, Ming; Li, Junhui; Guo, Chen; Jiang, Jie; Zhang, Ying; Ye, Qifa; Ming, Yingzi
细胞生物学
发表日期：2025
文献求助 收藏

Clinical performance evaluation of a plasma dual-target methylation test for the detection of primary liver cancer: a multicenter study

血浆双靶点甲基化检测在原发性肝癌检测中的临床性能评价：一项多中心研究

期刊:Clinical Epigenetics
影响因子:4.4
doi:10.1186/s13148-025-01920-1
Xu, Zhigao; Chen, Wanping; Wei, Hongsheng; Tan, Kui; Zhang, Lianglu; Dong, Lanlan; Liang, Wenjin; Zhou, Xin; Zhang, Tao; Chen, Jian; Peng, Chuang; Wang, Zhongxin; Ye, Shaojun; Ye, Qifa
肿瘤
肝癌
表观遗传
肿瘤免疫
发表日期：2025
文献求助 收藏

Mild hypothermia attenuates hepatic ischemia-reperfusion injury by regulating FoxO1/PPARα pathway

轻度低温通过调节FoxO1/PPARα通路减轻肝脏缺血再灌注损伤。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-09725-1
Lu, Zhongshan; Chen, Hao; Liu, Anxiong; Na, Shufang; Wang, Wei; Zhong, Zibiao; Ye, Qifa
信号转导
发表日期：2025
文献求助 收藏

Liver cirrhosis in 2021: Global Burden of Disease study

2021年肝硬化：全球疾病负担研究

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0328493
Duo, Hong; You, Jian; Du, Siqi; Yu, Mengran; Wu, Shaomei; Yue, Pengpeng; Cui, Xiao; Huang, Yihui; Luo, Jun; Pan, Huaqin; Ye, Qifa
肝硬化
发表日期：2025
文献求助 收藏

Structure-based identification of potent fibroblast growth factor receptor 4 (FGFR4) inhibitors as potential therapeutics for hepatocellular carcinoma

基于结构的强效成纤维细胞生长因子受体4 (FGFR4) 抑制剂鉴定及其作为肝细胞癌潜在治疗药物的价值

期刊:PeerJ
影响因子:2.4
doi:10.7717/peerj.19183
Fan, Lin; Xie, Hui; Wang, Weiyu; Peng, Guizhu; Fu, Zhen; Ye, Qifa
成纤维细胞
肿瘤
肿瘤免疫
FGFR4
信号转导
细胞生物学
发表日期：2025
文献求助 收藏